Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NYXH

+ Watchlist+ Portfolio

Nyxoah SA

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.88
52-Week Range
$0.80 – $5.39
Market Cap
$87.89M
P/E (TTM)
—
EPS (TTM)
-1.83
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.15
PEG Ratio
—
Return on Equity
-151.79%
Return on Assets
-42.06%
Gross Margin
61.09%
Operating Margin
-282.53%
Profit Margin
0.00%
Current Ratio
2.19
Debt/Equity
0.79
Total Debt
$53.86M
Free Cash Flow
$-46.00M
Revenue Growth
365.00%
Earnings Growth
—
Enterprise Value
$64.67M

Market Snapshot

About

Nyxoah is a Belgium-based medical technology company developing innovative neurostimulation therapy for obstructive sleep apnea. The company's lead product is a bilateral hypoglossal nerve stimulation system that treats moderate to severe sleep apnea.